These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33588016)

  • 1. Potential interventions for an antimicrobial stewardship bundle for Escherichia coli bacteraemia.
    Birrell MT; Horne K; Rogers BA
    Int J Antimicrob Agents; 2021 Apr; 57(4):106301. PubMed ID: 33588016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of antibiotic stewardship interventions in primary care on antimicrobial resistance of Escherichia coli bacteraemia in England (2013-18): a quasi-experimental, ecological, data linkage study.
    Aliabadi S; Anyanwu P; Beech E; Jauneikaite E; Wilson P; Hope R; Majeed A; Muller-Pebody B; Costelloe C
    Lancet Infect Dis; 2021 Dec; 21(12):1689-1700. PubMed ID: 34363774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of an antimicrobial stewardship program indicator on the appropriateness of the empiric antibiotic treatment of urinary source Escherichia coli bacteraemia.
    Giménez-Pérez M; Hernández S; Padullés A; Boix-Palop L; Grau S; Badia JM; Ferrer R; Calbo E; Limón E; Pujol M; Horcajada JP;
    Int J Antimicrob Agents; 2024 Aug; 64(2):107202. PubMed ID: 38768736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
    Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
    J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the relationship between primary care antibiotic prescribing for urinary tract infections, Escherichia coli bacteraemia incidence and antimicrobial resistance: an ecological study.
    Lishman H; Costelloe C; Hopkins S; Johnson AP; Hope R; Guy R; Muller-Pebody B; Holmes A; Aylin P
    Int J Antimicrob Agents; 2018 Dec; 52(6):790-798. PubMed ID: 30145249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors, outcome and impact of empirical antimicrobial treatment in extended-spectrum β-lactamase-producing Escherichia coli bacteraemia.
    Van Aken S; Lund N; Ahl J; Odenholt I; Tham J
    Scand J Infect Dis; 2014 Nov; 46(11):753-62. PubMed ID: 25195648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of an antimicrobial stewardship program on urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Esteve-Palau E; Grau S; Herrera S; Sorlí L; Montero M; Segura C; Durán X; Horcajada JP
    Rev Esp Quimioter; 2018 Apr; 31(2):110-117. PubMed ID: 29521484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical consequences of increased ciprofloxacin and gentamicin resistance in patients with Escherichia coli bacteraemia in the Netherlands.
    Cranendonk DR; van der Valk M; Langenberg ML; van der Meer JT
    Scand J Infect Dis; 2012 May; 44(5):363-8. PubMed ID: 22200089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study.
    Denis B; Lafaurie M; Donay JL; Fontaine JP; Oksenhendler E; Raffoux E; Hennequin C; Allez M; Socie G; Maziers N; Porcher R; Molina JM
    Int J Infect Dis; 2015 Oct; 39():1-6. PubMed ID: 26189774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteraemia due to AmpC β-lactamase-producing Escherichia coli in hospitalized cancer patients: risk factors, antibiotic therapy, and outcomes.
    Zhang Q; Zhang W; Li Z; Bai C; Li D; Zheng S; Zhang P; Zhang S
    Diagn Microbiol Infect Dis; 2017 Jul; 88(3):247-251. PubMed ID: 28434898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propensity score-matched analysis comparing the therapeutic efficacies of cefazolin and extended-spectrum cephalosporins as appropriate empirical therapy in adults with community-onset Escherichia coli, Klebsiella spp. and Proteus mirabilis bacteraemia.
    Hsieh CC; Lee CH; Hong MY; Hung YP; Lee NY; Ko WC; Lee CC
    Int J Antimicrob Agents; 2016 Dec; 48(6):712-718. PubMed ID: 27836382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategy to reduce
    Hsu D; Melzer M
    Postgrad Med J; 2018 Apr; 94(1110):212-215. PubMed ID: 29463684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent Escherichia coli bacteraemia--clinical characteristics and bacterial properties.
    Brauner A; Kaijser B; Kühn I
    J Infect; 1994 Jan; 28(1):49-57. PubMed ID: 8163833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling the implementation of narrow versus broader spectrum antibiotics in the empiric treatment of E. coli bacteraemia.
    Khurana MP; Curran-Sebastian J; Bhatt S; Knight GM
    Sci Rep; 2024 Jul; 14(1):16986. PubMed ID: 39043719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Descriptive epidemiology of Escherichia coli bacteraemia in England, April 2012 to March 2014.
    Bou-Antoun S; Davies J; Guy R; Johnson AP; Sheridan EA; Hope RJ
    Euro Surveill; 2016 Sep; 21(35):. PubMed ID: 27608263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ertapenem for treatment of extended-spectrum beta-lactamase-producing and multidrug-resistant gram-negative bacteraemia.
    Lye DC; Wijaya L; Chan J; Teng CP; Leo YS
    Ann Acad Med Singap; 2008 Oct; 37(10):831-4. PubMed ID: 19037516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral beta-lactam step down in bacteremic E. coli urinary tract infections.
    Saad S; Mina N; Lee C; Afra K
    BMC Infect Dis; 2020 Oct; 20(1):785. PubMed ID: 33087051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in resistance among coliform bacteraemia associated with a primary care antimicrobial stewardship intervention: A population-based interrupted time series study.
    Hernandez-Santiago V; Davey PG; Nathwani D; Marwick CA; Guthrie B
    PLoS Med; 2019 Jun; 16(6):e1002825. PubMed ID: 31173597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on: Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
    Blot S; Vandijck D; Vandewoude K; Depuydt P; Vogelaers D; Peleman R
    J Antimicrob Chemother; 2007 Dec; 60(6):1402. PubMed ID: 17913718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.